DNA Sequencing Services Market Snapshot (2023 to 2033)

The global DNA sequencing services market is anticipated to be valued at US$ 945.6 million in 2023. The market is forecast to expand at a CAGR of 8.2% from 2023 to 2033, valued at US$ 2,080.2 million by 2033. Growth is attributed to the increase in cancer cases around the world.

DNA sequencing determines the sequence of the four DNA bases: adenine, thymine, guanine, and cytosine. Adenine (A) always pairs with thymine (T); cytosine (C) always pairs with guanine (G). The sequencing of the DNA base pairs is important to establish the genetic information to be used further in determining regulatory instructions, gene positioning, and others.

Data Points Key Statistics
Growth Rate (2018 to 2022) US$ 6.7% CAGR
Expected Market Value (2023) US$ 945.6 million
Anticipated Forecast Value (2033) US$ 2,080.2 million
Projected Growth Rate (2023 to 2033) 8.2% CAGR

DNA sequencing has been used as an important tool in diagnosing chronic diseases as it highlights changes in the gene that causes disease. During the time of cell division, the base pairs are copied, and this is the fact that most of the experiments are carried out on the DNA bases.

Rapid advancements in sequencing technology and bioinformatics have enabled the identification of DNA variations, which are expected to boost the growth of the DNA sequencing services industry during the forecast period.

On the other hand, ethical and legal limitation associated with NGS is one of the crucial factors expected to hamper the growth of the DNA sequencing services industry over the analysis period.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Some Prominent Drivers Spearheading DNA Sequencing Services Market Growth

Factors such as the increase in cancer cases around the world, rising research studies, increasing collaborations between research institutes and market players, as well as rising applications of DNA next-generation sequencing and technological advancements in sequencing technologies, are all expected to accelerate the growth of the DNA sequencing services industry over the analysis period.

The need for DNA sequencing methods is expected to expand as research and development activities for treatments to treat genetic disorders increase. Substantial market demand may be created as research and development investments increase and studies related to treating genetic disorders among individuals grow.

Governments in industrialized economies have implemented programs and laws to encourage scientists and researchers to explore treatments for chronic and rare diseases.

Hospitals choose DNA sequencing techniques because they can deliver clinical diagnosis in less time, which helps the market grow. In addition, DNA sequencing can be utilized to collect the most up-to-date data and identify transmission links to avoid infections across hospital settings. All these factors are expected to propel the growth of the DNA sequencing services industry during the forecast period.

Challenges Faced by the DNA Sequencing Services Industry

The need for more skilled professionals is a key factor expected to hamper the growth of the DNA sequencing services market during the forecast period. Additionally, ethical and legal limitation associated with NGS is another key factor expected to impede the market growth over the analysis period.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

North America May Emerging as an Opportunistic DNA Sequencing Services Market

Region North America
Market Share % (2022) 40.6%

Regarding regional platforms, North America holds a significant market share in DNA sequencing services industry.

North America is the biggest DNA sequencing services industry market, attributed to several clinical laboratories that use NGS to offer genetic testing services, which drives the regional market.

Europe is Contributing Profoundly to the Growth of the DNA Sequencing Services Market

Region Europe
Market Share % (2022) 32.4%

According to Future Market Insights, Europe is expected to provide immense growth opportunities for DNA sequencing services and reach a significant share of more than 32.4% in 2023.

The DNA sequencing services market in Europe is expected to witness significant market growth, owing to many prominent market players in the region.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Role of Start-ups in the DNA Sequencing Services Market

Prominent market players in the DNA sequencing services industry are working hand-in-hand to provide the best-in-class DNA sequencing services for enhancing the global genetics arena.

However, many global start-ups in the DNA sequencing services market are stepping forward to match the requirements of the DNA sequencing services domain.

  • Hesaam Esfandyarpour founded Genapsys, a California-based company that develops DNA sequencing technologies and systems, in 2010. GenapSys raised US$ 75 million in February 2020 to fund the global expansion of its tabletop DNA sequencer to aid in the control of coronavirus in the region.
  • Otogenetics Corporation is a privately held corporation founded in 2007. The company's headquarters are in Atlanta, Georgia, the United States. Otogenetics Corporation, a high throughput NGS clinical laboratory, entered into an agreement with Swift Biosciences, Inc. in July 2020 to supply Swift 2S Turbo DNA Library Kits to ramp up its NGS-based clinical services.

Global Startups of DNA Sequencing Services Market

  • Ganit Labs
  • LifeCell International
  • Theramyt Novobiologics
  • Vitas Pharma Research
  • Achira Labs
  • BGI Genomics
  • Pacific Biosciences of California
  • New England Biolabs
  • GenapSys Inc.

Market Competition

Some key participants present in the global DNA sequencing services market include Illumina Inc., Thermo Fischer Scientific Inc., Oxford Nanopore Technologies Plc, Agilent Technologies, Inc., QIAGEN, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ, Inc., Hamilton Company, Macrogen Inc., Zymo Research Corporation, and Tecan Trading AG, among others.

Due to the presence of several leading participants, the market is highly competitive. Global players such as Illumina Inc., Thermo Fischer Scientific Inc., and Oxford Nanopore Technologies plc. Account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in North America.

Recent Developments

  • In December 2020, Eurofins Genomics released SARS-CoV-2 NGS services that are both cost-effective and optimized, allowing for entire viral genome sequencing.
  • In May 2020, Roche introduced the KAPA Target Enrichment portfolio and the KAPA HyperExome whole-exome research panel for target enrichment during sequencing.
  • Illumina recently received Emergency Use Authorization (EUA) from the FDA for its COVIDSeq Test, which is used to sequence the entire genome of the novel SARS-CoV-2 virus.
  • Face2Gene LABS was launched in June 2019 by PerkinElmer, Inc. and FDNA, an artificial intelligence company, to provide genomic services in conjunction with Next-Generation Phenotyping (NGP) technologies for more accurate and efficient diagnoses.

Report Scope

Attribute Details
Growth Rate CAGR of 8.2% from 2023 to 2033
Market Value in 2023 US$ 945.6 million
Market Value in 2033 US$ 2,080.2 million
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million, and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered
  • Product Type
  • End Use
  • Application
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel
Key Companies Profiled
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • GE Healthcare
  • Merck KGaA
  • Agilent Technologies Inc.
  • Roche Holdings AG
  • Pacific Biosciences
  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
Customization Available Upon Request

Key Segments Profiled in The DNA Sequencing Services Industry Survey

By Product Type:

  • Maxam–Gilbert DNA Sequencing
  • Chain-Termination Methods
  • Dye-Terminator Sequencing
  • Automation and Sample Preparation
  • Large-scale DNA Sequencing
  • New DNA Sequencing Methods
  • High Throughput DNA Sequencing
  • Parallel Signature Sequencing (MPSS)
  • Polony Sequencing
  • Pyrosequencing
  • Illumina (Solexa) Sequencing
  • SOLiD Sequencing
  • Others

By End Use:

  • Automotive Industry
  • Chemical Industry
  • Agriculture
  • Oil and Gas
  • Research and Development
  • Other End Uses

By Application:

  • Hospitals
  • Diagnostic Centers
  • Biotechnology and Pharmaceutical Industry
  • Academic Research Institutes
  • Other Application Areas

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa

Frequently Asked Questions

What is the Current Market Valuation?

The market is estimated to secure a valuation of US$ 945.6 million in 2023.

What is the Growth Forecast for the Market?

The market is forecast to register a CAGR of 8.2% through 2033.

How is the Historical Performance of the Market?

The market expanded at a CAGR of 6.7%

Which is the Top Trend in the Market?

Advances in sequencing and bioinformatics DNA variations are the top trend.

What is the Projected Size of the Market by 2033?

The global market size is estimated to reach US$ 2,080.2 million by 2033.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
        5.3.1. Maxam–Gilbert DNA Sequencing
        5.3.2. Chain-Termination Methods
        5.3.3. Dye-Terminator Sequencing
        5.3.4. Automation and Sample Preparation
        5.3.5. Large-Scale DNA Sequencing
        5.3.6. New DNA Sequencing Methods
        5.3.7. High Throughput DNA Sequencing
        5.3.8. Parallel Signature Sequencing (MPSS)
        5.3.9. Polony Sequencing
        5.3.10. Pyrosequencing
        5.3.11. SOLiD Sequencing
        5.3.12. Others
    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
        6.3.1. Clinical Investigation
        6.3.2. Oncology
        6.3.3. Forensics & Agrigenomics
        6.3.4. Reproductive Health
        6.3.5. HLA Typing
        6.3.6. Others
    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-Use
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis by End-Use, 2018 to 2022
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End-Use, 2023 to 2033
        7.3.1. Clinical Research
        7.3.2. Academic Research
        7.3.3. Biotechnology & Pharmaceutical Companies
        7.3.4. Hospitals & Clinics
        7.3.5. Others
    7.4. Y-o-Y Growth Trend Analysis by End-Use, 2018 to 2022
    7.5. Absolute $ Opportunity Analysis by End-Use, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    8.1. Introduction
    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
        8.3.1. North America
        8.3.2. Latin America
        8.3.3. Western Europe
        8.3.4. Eastern Europe
        8.3.5. South Asia and Pacific
        8.3.6. East Asia
        8.3.7. Middle East and Africa
    8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        9.2.1. By Country
            9.2.1.1. The USA
            9.2.1.2. Canada
        9.2.2. By Product Type
        9.2.3. By Application
        9.2.4. By End-Use
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Product Type
        9.3.3. By Application
        9.3.4. By End-Use
    9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. Brazil
            10.2.1.2. Mexico
            10.2.1.3. Rest of Latin America
        10.2.2. By Product Type
        10.2.3. By Application
        10.2.4. By End-Use
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product Type
        10.3.3. By Application
        10.3.4. By End-Use
    10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Germany
            11.2.1.2. United Kingdom
            11.2.1.3. France
            11.2.1.4. Spain
            11.2.1.5. Italy
            11.2.1.6. Rest of Western Europe
        11.2.2. By Product Type
        11.2.3. By Application
        11.2.4. By End-Use
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product Type
        11.3.3. By Application
        11.3.4. By End-Use
    11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. Poland
            12.2.1.2. Russia
            12.2.1.3. Czech Republic
            12.2.1.4. Romania
            12.2.1.5. Rest of Eastern Europe
        12.2.2. By Product Type
        12.2.3. By Application
        12.2.4. By End-Use
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product Type
        12.3.3. By Application
        12.3.4. By End-Use
    12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. India
            13.2.1.2. Bangladesh
            13.2.1.3. Australia
            13.2.1.4. New Zealand
            13.2.1.5. Rest of South Asia and Pacific
        13.2.2. By Product Type
        13.2.3. By Application
        13.2.4. By End-Use
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product Type
        13.3.3. By Application
        13.3.4. By End-Use
    13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. China
            14.2.1.2. Japan
            14.2.1.3. South Korea
        14.2.2. By Product Type
        14.2.3. By Application
        14.2.4. By End-Use
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product Type
        14.3.3. By Application
        14.3.4. By End-Use
    14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        15.2.1. By Country
            15.2.1.1. GCC Countries
            15.2.1.2. South Africa
            15.2.1.3. Israel
            15.2.1.4. Rest of MEA
        15.2.2. By Product Type
        15.2.3. By Application
        15.2.4. By End-Use
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Product Type
        15.3.3. By Application
        15.3.4. By End-Use
    15.4. Key Takeaways
16. Key Countries Market Analysis
    16.1. USA
        16.1.1. Pricing Analysis
        16.1.2. Market Share Analysis, 2022
            16.1.2.1. By Product Type
            16.1.2.2. By Application
            16.1.2.3. By End-Use
    16.2. Canada
        16.2.1. Pricing Analysis
        16.2.2. Market Share Analysis, 2022
            16.2.2.1. By Product Type
            16.2.2.2. By Application
            16.2.2.3. By End-Use
    16.3. Brazil
        16.3.1. Pricing Analysis
        16.3.2. Market Share Analysis, 2022
            16.3.2.1. By Product Type
            16.3.2.2. By Application
            16.3.2.3. By End-Use
    16.4. Mexico
        16.4.1. Pricing Analysis
        16.4.2. Market Share Analysis, 2022
            16.4.2.1. By Product Type
            16.4.2.2. By Application
            16.4.2.3. By End-Use
    16.5. Germany
        16.5.1. Pricing Analysis
        16.5.2. Market Share Analysis, 2022
            16.5.2.1. By Product Type
            16.5.2.2. By Application
            16.5.2.3. By End-Use
    16.6. United Kingdom
        16.6.1. Pricing Analysis
        16.6.2. Market Share Analysis, 2022
            16.6.2.1. By Product Type
            16.6.2.2. By Application
            16.6.2.3. By End-Use
    16.7. France
        16.7.1. Pricing Analysis
        16.7.2. Market Share Analysis, 2022
            16.7.2.1. By Product Type
            16.7.2.2. By Application
            16.7.2.3. By End-Use
    16.8. Spain
        16.8.1. Pricing Analysis
        16.8.2. Market Share Analysis, 2022
            16.8.2.1. By Product Type
            16.8.2.2. By Application
            16.8.2.3. By End-Use
    16.9. Italy
        16.9.1. Pricing Analysis
        16.9.2. Market Share Analysis, 2022
            16.9.2.1. By Product Type
            16.9.2.2. By Application
            16.9.2.3. By End-Use
    16.10. Poland
        16.10.1. Pricing Analysis
        16.10.2. Market Share Analysis, 2022
            16.10.2.1. By Product Type
            16.10.2.2. By Application
            16.10.2.3. By End-Use
    16.11. Russia
        16.11.1. Pricing Analysis
        16.11.2. Market Share Analysis, 2022
            16.11.2.1. By Product Type
            16.11.2.2. By Application
            16.11.2.3. By End-Use
    16.12. Czech Republic
        16.12.1. Pricing Analysis
        16.12.2. Market Share Analysis, 2022
            16.12.2.1. By Product Type
            16.12.2.2. By Application
            16.12.2.3. By End-Use
    16.13. Romania
        16.13.1. Pricing Analysis
        16.13.2. Market Share Analysis, 2022
            16.13.2.1. By Product Type
            16.13.2.2. By Application
            16.13.2.3. By End-Use
    16.14. India
        16.14.1. Pricing Analysis
        16.14.2. Market Share Analysis, 2022
            16.14.2.1. By Product Type
            16.14.2.2. By Application
            16.14.2.3. By End-Use
    16.15. Bangladesh
        16.15.1. Pricing Analysis
        16.15.2. Market Share Analysis, 2022
            16.15.2.1. By Product Type
            16.15.2.2. By Application
            16.15.2.3. By End-Use
    16.16. Australia
        16.16.1. Pricing Analysis
        16.16.2. Market Share Analysis, 2022
            16.16.2.1. By Product Type
            16.16.2.2. By Application
            16.16.2.3. By End-Use
    16.17. New Zealand
        16.17.1. Pricing Analysis
        16.17.2. Market Share Analysis, 2022
            16.17.2.1. By Product Type
            16.17.2.2. By Application
            16.17.2.3. By End-Use
    16.18. China
        16.18.1. Pricing Analysis
        16.18.2. Market Share Analysis, 2022
            16.18.2.1. By Product Type
            16.18.2.2. By Application
            16.18.2.3. By End-Use
    16.19. Japan
        16.19.1. Pricing Analysis
        16.19.2. Market Share Analysis, 2022
            16.19.2.1. By Product Type
            16.19.2.2. By Application
            16.19.2.3. By End-Use
    16.20. South Korea
        16.20.1. Pricing Analysis
        16.20.2. Market Share Analysis, 2022
            16.20.2.1. By Product Type
            16.20.2.2. By Application
            16.20.2.3. By End-Use
    16.21. GCC Countries
        16.21.1. Pricing Analysis
        16.21.2. Market Share Analysis, 2022
            16.21.2.1. By Product Type
            16.21.2.2. By Application
            16.21.2.3. By End-Use
    16.22. South Africa
        16.22.1. Pricing Analysis
        16.22.2. Market Share Analysis, 2022
            16.22.2.1. By Product Type
            16.22.2.2. By Application
            16.22.2.3. By End-Use
    16.23. Israel
        16.23.1. Pricing Analysis
        16.23.2. Market Share Analysis, 2022
            16.23.2.1. By Product Type
            16.23.2.2. By Application
            16.23.2.3. By End-Use
17. Market Structure Analysis
    17.1. Competition Dashboard
    17.2. Competition Benchmarking
    17.3. Market Share Analysis of Top Players
        17.3.1. By Regional
        17.3.2. By Product Type
        17.3.3. By Application
        17.3.4. By End-Use
18. Competition Analysis
    18.1. Competition Deep Dive
        18.1.1. Thermo Fisher Scientific Inc.
            18.1.1.1. Overview
            18.1.1.2. Product Portfolio
            18.1.1.3. Profitability by Market Segments
            18.1.1.4. Sales Footprint
            18.1.1.5. Strategy Overview
                18.1.1.5.1. Marketing Strategy
        18.1.2. Abbott Laboratories
            18.1.2.1. Overview
            18.1.2.2. Product Portfolio
            18.1.2.3. Profitability by Market Segments
            18.1.2.4. Sales Footprint
            18.1.2.5. Strategy Overview
                18.1.2.5.1. Marketing Strategy
        18.1.3. GE Healthcare
            18.1.3.1. Overview
            18.1.3.2. Product Portfolio
            18.1.3.3. Profitability by Market Segments
            18.1.3.4. Sales Footprint
            18.1.3.5. Strategy Overview
                18.1.3.5.1. Marketing Strategy
        18.1.4. Merck KGaA
            18.1.4.1. Overview
            18.1.4.2. Product Portfolio
            18.1.4.3. Profitability by Market Segments
            18.1.4.4. Sales Footprint
            18.1.4.5. Strategy Overview
                18.1.4.5.1. Marketing Strategy
        18.1.5. Agilent Technologies Inc.
            18.1.5.1. Overview
            18.1.5.2. Product Portfolio
            18.1.5.3. Profitability by Market Segments
            18.1.5.4. Sales Footprint
            18.1.5.5. Strategy Overview
                18.1.5.5.1. Marketing Strategy
        18.1.6. Roche Holdings AG
            18.1.6.1. Overview
            18.1.6.2. Product Portfolio
            18.1.6.3. Profitability by Market Segments
            18.1.6.4. Sales Footprint
            18.1.6.5. Strategy Overview
                18.1.6.5.1. Marketing Strategy
        18.1.7. Pacific Biosciences
            18.1.7.1. Overview
            18.1.7.2. Product Portfolio
            18.1.7.3. Profitability by Market Segments
            18.1.7.4. Sales Footprint
            18.1.7.5. Strategy Overview
                18.1.7.5.1. Marketing Strategy
        18.1.8. Illumina Inc.
            18.1.8.1. Overview
            18.1.8.2. Product Portfolio
            18.1.8.3. Profitability by Market Segments
            18.1.8.4. Sales Footprint
            18.1.8.5. Strategy Overview
                18.1.8.5.1. Marketing Strategy
        18.1.9. Bio-Rad Laboratories Inc.
            18.1.9.1. Overview
            18.1.9.2. Product Portfolio
            18.1.9.3. Profitability by Market Segments
            18.1.9.4. Sales Footprint
            18.1.9.5. Strategy Overview
                18.1.9.5.1. Marketing Strategy
        18.1.10. Myriad Genetics
            18.1.10.1. Overview
            18.1.10.2. Product Portfolio
            18.1.10.3. Profitability by Market Segments
            18.1.10.4. Sales Footprint
            18.1.10.5. Strategy Overview
                18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Recommendations

Healthcare

Cell-free Fetal DNA Testing Market

August 2023

REP-GB-1212

333 pages

Healthcare

DNA/RNA Extraction Market

June 2023

REP-GB-10543

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

DNA Sequencing Services Market

Schedule a Call